Photocrosslinked poly(ester anhydride)s for peptide delivery: Effect of oligomer hydrophobicity on PYY3-36 delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 1, 2012, Pages 33-38

  Mönkäre, Juha ^a   Hakala, Risto A ^b   Kovalainen, Miia ^a   Korhonen, Harri ^b   Herzig, Karl Heinz ^c,d   Seppälä, Jukka V ^b   Järvinen, Kristiina ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bioavailability; Controlled release; Peptide YY3 36; Pharmacokinetics; Photocrosslinking; Poly(ester anhydride)

Indexed keywords

PEPTIDE YY [3-36]; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PROTEIN CROSS LINKING; RAT; ROOM TEMPERATURE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPODERMOCLYSIS; MALE; PEPTIDE YY; POLYMERS; POWDERS; RATS; RATS, WISTAR; SUCCINIC ANHYDRIDES;

EID: 83955165905     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.09.011     Document Type: Article

References (38)

1. S. Frokjaer, and D.E. Otzen Protein drug stability: a formulation challenge Nat. Rev. Drug Discovery 4 2005 298 306 (Pubitemid 41130943)
2. M.R. Park, C. Chun, C.S. Cho, and S.C. Song Enhancement of sustained and controlled protein release using polyelectrolyte complex-loaded injectable and thermosensitive hydrogel Eur. J. Pharm. Biopharm. 76 2010 179 188
3. G. Schwach, N. Oudry, J.P. Giliberto, P. Broqua, M. Luck, H. Lindner, and R. Gurny Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: Part II. In vivo performance Eur. J. Pharm. Biopharm. 57 2004 441 446 (Pubitemid 38490560)
4. S. Chen, and J. Singh Controlled release of growth hormone from thermosensitive triblock copolymer systems: in vitro and in vivo evaluation Int. J. Pharm. 352 2008 58 65 (Pubitemid 351284586)
5. M. Katakam, W.R. Ravis, and A.K. Banga Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels J. Controlled Release 49 1997 21 26 (Pubitemid 27417897)
6. A. Göpferich Mechanisms of polymer degradation and erosion Biomaterials 17 1996 103 114 (Pubitemid 26031366)
7. H. Korhonen, R. Hakala, A. Helminen, and J. Seppälä Synthesis and hydrolysis behaviour of poly(ester anhydrides) from polylactone precursors containing alkenyl moieties Macromol. Biosci. 6 2006 496 505 (Pubitemid 44105946)
8. J. Mönkäre, R.A. Hakala, M.A. Vlasova, A. Huotari, M. Kilpeläinen, A. Kiviniemi, V. Meretoja, K.H. Herzig, H. Korhonen, J.V. Seppälä, and K. Järvinen Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly (-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo J. Controlled Release 146 2010 349 355
9. A.C. Albertsson, and I.K. Varma Recent developments in ring opening polymerization of lactones for biomedical applications Biomacromolecules 4 2003 1466 1486 (Pubitemid 37460959)
10. A. Göpferich, and J. Tessmar Polyanhydride degradation and erosion Adv. Drug Deliv. Rev. 54 2002 911 931
11. R. Hakala, H. Korhonen, S. Holappa, and J. Seppala Hydrophobicities of poly(-caprolactone) oligomers functionalized with different succinic anhydrides Eur. Polym. J. 45 2009 557 564
12. M. Neary, and R. Batterham Gut hormones: implications for the treatment of obesity Pharmacol. Ther. 124 2009 44 56
13. K. Tatemoto, and V. Mutt Isolation of 2 novel candidate hormones using a chemical method for finding naturally-occurring polypeptides Nature 285 1980 417 418 (Pubitemid 10047227)
14. R. Batterham, M. Cowley, C. Small, H. Herzog, M. Cohen, C. Dakin, A. Wren, A. Brynes, M. Low, M. Ghatei, R. Cone, and S. Bloom Gut hormone PYY3-36 physiologically inhibits food intake Nature 418 2002 650 654
15. L. Degen, S. Oesch, M. Casanova, S. Graf, S. Ketterer, J. Drewe, and C. Beglinger Effect of peptide YY3-36 on food intake in humans Gastroenterology 129 2005 1430 1436 (Pubitemid 41597385)
16. R.L. Batterham, M.A. Cohen, S.M. Ellis, C.W. Le Roux, D.J. Withers, G.S. Frost, M.A. Ghatei, and S.R. Bloom Inhibition of food intake in obese subjects by peptide YY3-36 New Engl. J. Med. 349 2003 941 948 (Pubitemid 37064767)
17. A.P. Sileno, G.C. Brandt, B.M. Spann, and S.C. Quay Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits Int. J. Obesity 30 2005 68 72 (Pubitemid 41790779)
18. P.K. Chelikani, A.C. Haver, J.R. Reeve, D.A. Keire, and R.D. Reidelberger Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats Am. J. Physiol-Regul. Integr. Comp. Physiol. 290 2006 R298 R305
19. I. Gantz, N. Erondu, M. Mallick, B. Musser, R. Krishna, W.K. Tanaka, K. Snyder, C. Stevens, M.A. Stroh, H.Y. Zhu, J.A. Wagner, D.J. MacNeil, S.B. Heymsfield, and J.M. Amatruda Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults J. Clin. Endocrinol. Metab. 92 2007 1754 1757 (Pubitemid 46997183)
20. R. Steinert, B. Poller, C. Castelli, J. Drewe, and C. Beglinger Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects Am. J. Clin. Nutr. 92 2010 810 817
21. B. Sloth, L. Davidsen, J. Holst, A. Flint, and A. Astrup Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males Am. J. Physiol-Endocrinol. Metab. 293 2007 E604 E609
22. A. Helminen, H. Korhonen, and J. Seppälä Crosslinked poly(ester anhydride)s based on poly(-caprolactone) and polylactide oligomers J. Polym. Sci. Polym. Chem. 41 2003 3788 3797 (Pubitemid 37454089)
23. J.A. Burdick, A.J. Peterson, and K.S. Anseth Conversion and temperature profiles during the photoinitiated polymerization of thick orthopaedic biomaterials Biomaterials 22 2001 1779 1786 (Pubitemid 32564966)
24. D. Chu, X. Fu, W. Liu, K. Liu, and Y. Li Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs Int. J. Pharm. 325 2006 116 123 (Pubitemid 44573702)
25. S. Siegel, and N.J. Castellan Jr. The case of k independent samples J.D. Anker, Nonparametric Statistics for the Behavioral Sciences second ed. 1988 McGraw-Hill Inc. New York 190 223
26. A. Gopferich, L. Schedl, and R. Langer The precipitation of monomers during the erosion of a class of polyanhydrides Polymer 37 1996 3861 3869 (Pubitemid 126692425)
27. M.J. Kipper, and B. Narasimhan Molecular description of erosion phenomena in biodegradable polymers Macromolecules 38 2005 1989 1999 (Pubitemid 40384618)
28. N. Nonaka, S. Shioda, M. Niehoff, and W. Banks Characterization of blood-brain barrier permeability to PYY3-36 in the mouse J. Pharmacol. Exp. Ther. 306 2003 948 953 (Pubitemid 37025300)
29. C. Beglinger, B. Poller, E. Arbit, C. Ganzoni, S. Gass, I. Gomez-Orellana, and J. Drewe Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof-of-concept study in healthy subjects Clin. Pharmacol. Ther. 84 2008 468 474
30. H.R. Constantino, M.S. Kleppe, A. Stoudt Cohen, A.P. Sileno, Intranasal PYY formulations with improved transmucosal pharmacokinetics, US Patent Application No. US 2007/0232537 A1, 2007.
31. Y. Tabata, S. Gutta, and R. Langer Controlled delivery of systems for proteins using polyanhydride microspheres Pharm. Res. 10 1993 487 496 (Pubitemid 23113038)
32. K. Mäder, Y. Crémmilleux, A. Domb, J. Dunn, and H. Swartz In vitro/in vivo comparison of drug release and polymer erosion from biodegradable P(FAD-SA) polyanhydrides - a noninvasive approach by the combined use of electron paramagnetic resonance spectroscopy and nuclear magnetic resonance imaging Pharm. Res. 14 1997 820 826 (Pubitemid 27281681)
33. M. Changez, V. Koul, B. Krishna, A.K. Dinda, and V. Choudhary Studies on biodegradation and release of gentamicin sulphate from interpenetrating network hydrogels based on poly(acrylic acid) and gelatin: in vitro and in vivo Biomaterials 25 2004 139 146 (Pubitemid 37324407)
34. M. Pulkkinen, M. Malin, J. Bohm, T. Tarvainen, T. Wirth, J. Seppala, and K. Jarvinen In vivo implantation of 2,2′-bis(oxazoline)-linked poly-ε-caprolactone: proof for enzyme sensitive surface erosion and biocompatibility Eur. J. Pharm. Sci. 36 2009 310 319
35. R.A. Pittner, C.X. Moore, S.P. Bhavsar, B.R. Gedulin, P.A. Smith, C.M. Jodka, D.G. Parkes, J.R. Paterniti, V.P. Srivastava, and A.A. Young Effects of PYY[3-36] in rodent models of diabetes and obesity Int. J. Obes. Relat. Metab. Disord. 28 2004 963 971 (Pubitemid 38998700)
36. R. Moriya, S. Mashiko, A. Ishihara, T. Takahashi, T. Murai, J. Ito, Y. Mitobe, Z. Oda, H. Iwaasa, F. Takehiro, and A. Kanatani Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice Peptides 30 2009 1318 1322
37. C.J.H. Porter, and S.A. Charman Lymphatic transport of proteins after subcutaneous administration J. Pharm. Sci. 89 2000 297 310 (Pubitemid 30152431)
38. M. Rowland, and T.N. Tozer Clinical Pharmacokinetics: Concepts and Applications third ed. 1995 Lippincott Williams & Wilkinson Philadelphia